Durable remission with Bruton's tyrosine kinase inhibitor therapy in a patient with leptomeningeal disease secondary to relapsed mantle cell lymphoma.
BMJ Case Rep. 2022 Jun 22;15(6):e249631. doi: 10.1136/bcr-2022-249631.
BMJ Case Rep. 2022.
PMID: 35732356